PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Ages 18 and older at time of diagnosis
• Patient diagnosed with stage II and III non-small cell lung cancer (NSCLC)
• Patient receives either neoadjuvant chemotherapy or immunotherapy and surgery
• Patient able to follow direction and complete questionnaires in English or Spanish
• Patient agrees to complete the PERCC intervention
Locations
United States
Texas
University of Texas Medical Branch at Galveston
RECRUITING
Galveston
Utah
Huntsman Cancer Institute
RECRUITING
Salt Lake City
Contact Information
Primary
Thomas Varghese, MD, MS, MBA, FACS
thomas.varghese@hsc.utah.edu
801-581-5311
Backup
Cornelia Ulrich, MS, PhD
neli.ulrich@hci.utah.edu
801-213-5716
Time Frame
Start Date: 2025-11-21
Estimated Completion Date: 2030-12
Participants
Target number of participants: 20
Treatments
Experimental: Precision Exercise Regimen for Cancer Care (PERCC)
Participants will engage in PERCC starting at least two weeks prior to receiving their first neoadjuvant treatment for lung cancer and continuing until two months after receiving surgical treatment.
Related Therapeutic Areas
Sponsors
Leads: University of Utah